Cite

HARVARD Citation

    Tonyali, O. et al. (2016). Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab. Breast. pp. 22-26. [Online]. 
  
Back to record